CONSOLIDATED BALANCE SHEETS (UNAUDITED) (EUR €) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Current Assets
Cash	€ 210	€ 286
Receivable other	35	43
Prepaid expenses	49	52
Total current assets	294	381
Property and equipment, net of accumulated depreciation of E270 at June 30, 2013 and E261 at December 31, 2012	77	28
In-process research and development	2,266	2,266
Goodwill	6,671	6,671
Total assets	9,308	9,346
Current Liabilities
Accounts payable	813	1,325
Current portion of convertible notes payable to related parties	37,520	34,723
Total current liabilities	38,333	36,048
Acquisition-related contingent consideration	250	6,533
Total liabilities	38,583	42,581
Shareholders' Equity (Deficit)
Common stock, U.S. $.01 par value; 495,000,000 shares authorized; issued 295,318,813 at June 30, 2013 and at December 31, 2012	2,468	2,468
Preferred stock, U.S. $.01 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	33,786	33,783
Deficit accumulated during the development stage	(66,242)	(70,168)
Accumulated other comprehensive income	713	682
Total shareholders' equity (deficit)	(29,275)	(33,235)
Total liabilities and shareholders' equity (deficit)	€ 9,308	€ 9,346